SEC Filing Summary: AntriaBio, Inc. (Form 8-K)
Business Context and Reporting Period
This Current Report on Form 8-K was filed by AntriaBio, Inc. (not Rezolute, Inc.) on December 6, 2017, covering events occurring on November 30, 2017. The registrant is a Delaware corporation headquartered in Louisville, Colorado.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance changes.
Material Changes
On November 30, 2017, Barry Sherman resigned from his position as a member of the Board of Directors. The Company stated that the resignation was not the result of any disagreements regarding operations, policies, or practices.
Outlook and Risks
The filing contains no guidance, outlook, or discussion of risks, contingencies, or unusual items beyond the board departure.
Key Facts for Investors
- Barry Sherman resigned from the Board of Directors effective November 30, 2017.
- The resignation was amicable and unrelated to any disputes with the Company.
- No financial data or operational updates were included in this specific filing.